The official blog of the Lung Institute.

What is My Why? Sarah Hocutt

11 Jan 2018
| Under Featured | Posted by | 0 Comments
What Is My Why_Sarah

A featured series where Lung Institute employees tell their stories #WhatIsMyWhy

I am the Patient Relations Manager for the Lung Institute and have worked here for almost three years.

I moved from Wisconsin where I worked in retail and for a big sporting goods manufacturer.

Growing up, my grandfather had COPD, but I didn’t really realize that’s what he had. He had breathing problems and often used an inhaler. That was just the way grandpa was. I didn’t give it a thought.

He played with his grandkids all the time and attended all the school events and other events we had while growing up.

Unfortunately, he eventually passed away from COPD.

When I interviewed at the Lung Institute, I did my research, and it hit me that this company was doing something that could have helped my grandfather had it been around at the time. I wanted to be a part of that.

Now that I have been here a few years, I realized that I had the opportunity to make a difference in people’s lives and being part of something bigger than me.

It’s easy to see the hope that we give to patients. Many of us see that almost every day when we meet them as they come in for treatments. We develop relationships through these meetings and also the many telephone calls and emails.

What is My Why?: Sarah Hocutt:

But that patient is someone’s mom or dad, brother or sister, son or daughter, and often a husband or wife. We don’t usually see that, but we now are all aware that this person belongs to a family and they are turning to us to keep this family going.

We are not naïve to this fact. We are affecting families larger than we can fathom. This is the reason I walk through those doors and into the Lung Institute every morning.

I’m proud and privileged to work for a group of patient coordinators who continually push the status quo.

We not only give hope to many, but we also are on the front lines of changing lung disease stigmas.

What we’ve been able to do is impressive, but it is nothing compared to what the future holds.  As a team, we will triumph through the challenges and celebrate the victories along the way.


* Every patient is given a Patient Satisfaction Survey shortly after treatment. Responses to the 11-question survey are aggregated to determine patient satisfaction with the delivery of treatment.

^ Quality of Life Survey data measured the patient’s self-assessed quality of life and measurable quality of improvement at three months of COPD patients.

All claims made regarding the efficacy of Lung Institute's treatments as they pertain to pulmonary conditions are based solely on anecdotal support collected by Lung Institute. Individual conditions, treatment and outcomes may vary and are not necessarily indicative of future results. Testimonial participation is voluntary. Lung Institute does not pay for or script patient testimonials.

As required by Texas state law, the Lung Institute Dallas Clinic has received Institutional Review Board (IRB) approval from MaGil IRB, now Chesapeake IRB, which is fully accredited by the Association for the Accreditation of Human Research Protection Program (AAHRPP), for research protocols and procedures. The Lung Institute has implemented these IRB approved standards at all of its clinics nationwide. Approval indicates that we follow rigorous standards for ethics, quality, and protections for human research.

Each patient is different. Results may vary.